|
|
|
|
|
|
| Open:
|
0.41 |
|
Volume:
|
16950 |
| High:
|
0.44 |
|
52Wk High:
|
0.94 |
| Low:
|
0.32 |
|
52Wk Low:
|
0.15 |
|
|
|
|
|
|
|
|
|
|
|
24 Frank Lloyd Wright Drive
Ann Arbor, MI 48106, US
|
|
Biological Products, Except Diagnostic Substances |
| |
|
|
|
 |
 |
|
 |
|
Free Registration enables all site features including Email Alerts, RSS Feeds, Charts & Reports, SEC Filings, and Executive & Company Profiles.
|
 |
 |
 |
 |
|
|
 |
|
 |
|
|
|
|
Board Member Report includes all current and historical board members, their board committees, whether they are the chair of each committee, the date they became a member of the board and their Job Title if they are also an executive of the firm. Also, you can create an email alert for any board member right from the Board Member report!
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEC filings are made available through
SECFilings.com – our free SEC filings portal with e-mail alert
and RSS capabilities. Clicking on the links to the left will bring you to the
corresponding page on SECFilings.com where you can login with your
ExecutiveDisclosure.com username and password to instantly view filings and
setup e-mail or RSS alerts.
|
|
 |
 |
 |
|
|
|
|
Company Average Compensation vs. Average Compensation for all Same Market Cap Companies in Same Industry chart compares the average pay for the company against all companies in the same industry and market cap using actual dollar figures.
|
|
|
|
|
|
 |
|
 |
|
|
 |
|
|
|
|
Company Average Compensation vs. Industry Average Compensation chart compares the average pay for the company against all companies in the same industry using actual dollar figures, making it easy to see how the current company's compensation practices compare against the industry average.
|
|
|
|
|
|
|
|
|
|
|
|
Company Average Compensation % Trend vs. Company Stock Prices % Trend chart compares the year over year percentage change in the average compensation package against the year over year percentage change in the company's stock price.
|
|
|
|
|
|
 |
|
|
 |
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| Gerald D. Brennan, Jr., J.D. joined Aastrom in July 2005 as its Vice President Administrative & Financial Operations and Chief Financial Officer. He comes to the Company from Great Lakes Chemical Corporation, where he served as Director New... (Read
more) |
|
07/2005
239583.00 |
|
|
|
|
| |
|
|
|
|
| Timothy M. Mayleben, a Director since June 2005, is an advisor to life science and healthcare companies through his advisory and investment firm, ElMa Advisors. Prior to this he served as the President and Chief Operating Officer and a Director of... (Read
more) |
|
06/20/2005
416827.00 |
|
|
|
|
| |
|
|
|
|
| Janet M. Hock, B.D.S., Ph.D., joined Aastrom in September 2004 as its Vice President Global Research, and also became Chief Scientific Officer in May 2005. She was previously on the faculty of Indiana University Schools of Medicine and Dentistry... (Read
more) |
|
09/2004
233417.00 |
|
|
|
|
| |
|
|
|
|
| Nelson M. Sims, a Director since February 2006, has over 30 years of experience in senior management of companies in the pharmaceutical industry. From 2003 through 2005, he served as President of Novavax, Inc., a specialty biopharmaceutical company.... (Read
more) |
|
02/09/2006
|
|
|
|
|
| |
|
|
|
|
| George W. Dunbar has served as President and Chief Executive Officer and as a Director since July 2006. He has more than thirty years of experience in the healthcare field, including the biotech, pharmaceutical, diagnostic and device sectors. During... (Read
more) |
|
07/17/2006
07/17/2006
359375.00 |
|
|
| | |